Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase 2/3 2Phase 2 2Phase 3 1

Status

Withdrawn 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1

Conditions

Depression 4Anxiety Disorders 3Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1

Interventions

Ketamine 4Typhoid-Paratyphoid Vaccines 1Psilocybin 1Niacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Depression × Ketamine × Clear all
NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

NCT05344625 2024-01-24

KAPTIVATED

Northwell Health

Phase EARLY_PHASE1 Withdrawn

Anxiety Disorders, Depression

NCT02442739 2018-11-06

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Withdrawn
GastrointestinalHead & Neck

Depression, Head and Neck Neoplasms, Pancreatic Neoplasms

NCT02836288 2018-11-06

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Completed
4 enrolled

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡